Grand Rounds, March 7, 2024

March 6, 2024

Presentation Title: My Early Years as a Surgeon Scientist: Navigating Liver Cancer Surgery and the Perioperative Window of Opportunity

Speaker: Samer Tohme, MD

Date: Thursday, March 7, 2024
Time: 7:00 AM ‐ 8:00 AM
Location: Medical School Building
Learning Format: In‐Person

Learning Objectives:
At the conclusion of this activity, participants should be able to:

  • Describe the challenges encountered when starting a career as a surgeon scientist
  • Understand the different perioperative inflammatory changes that can contribute to tumor growth
  • List some interventions that can be employed to counter inflammation driven tumor growth

Accreditation Statement:
McGovern Medical School at the University of Texas Health Science Center at Houston is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation:

  • McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for a maximum of 1
    AMA PRA Category 1Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for a maximum of 1 Hour(s) Attendance w/No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.

ABS MOC Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self‐Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Event Disclosures:

Speakers:
Samer Tohme, MD has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Planners and other Administrative Support:
David Lubkin, MD, Ashley Dawson, MD, Sasha Adams, MD, David Kim, MD, and Nicole Harris, MD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Lillian Kao, MD, Professor, Surgery has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re‐selling, or distributing healthcare products used by or on patients:

  • Wolters Kluwer ‐ Editor of Section in UpToDate ‐ Relationship Ended

Any financial relationship that was found to be relevant has been mitigated.

Commercial Support:
This activity is not commercially supported.

Related topics